← All trials
NCT06999993
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 20, 2025
- Primary completion
- May 31, 2026
- Completion date
- May 31, 2026
- First posted
- May 31, 2025
- Last posted
- Jul 29, 2025
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Misr University for Science and TechnologyLead sponsor
- Misr University for Science and TechnologySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.